NVIDIA Q2 Holdings: 91% Position Heavily Invested in "Favorite Child" CoreWeave Holdings Value Soars to $4.3 Billion

According to the Zhitong Finance APP, CoreWeave (CRWV.US), known as the "favorite son of NVIDIA (NVDA.US)," continued to receive support from the chip giant in the second quarter. According to the latest 13F regulatory filings disclosed by the U.S. Securities and Exchange Commission (SEC), NVIDIA's total market value in Q2 was $4.33 billion, up from $1.15 billion in the previous quarter. Notably, NVIDIA only increased its holdings in this cloud AI infrastructure service provider and did not establish, reduce, or liquidate positions in other securities. As of the end of the quarter, NVIDIA held approximately 24.28 million shares of CoreWeave, with a market value of about $3.959 billion, accounting for 91.36% of its portfolio. The number of shares increased by 0.39% compared to the previous quarter, making it NVIDIA's largest holding. CoreWeave is a company that provides cloud leasing services for NVIDIA graphics processors for AI model training and went public on NASDAQ in late March this year. Before its IPO, the company raised billions of dollars through equity and debt financing, with NVIDIA being one of the key investors. As of June 30, CoreWeave has risen approximately 318% since its IPO. However, the stock price has since retreated and recently plummeted due to a surge in losses and guidance that fell short of expectations. Next, the company will face a severe test with its first large-scale lock-up expiration post-IPO. According to FactSet data, about 84% of Class A shares of CoreWeave will be unlocked on Friday, primarily held by insiders, including co-founder and CEO Mike Intrator and NVIDIA. Among other holdings, Arm (ARM.US) ranks second, with approximately 1.1 million shares and a market value of about $178 million, accounting for 10.25% of the portfolio. Data center operator Applied Digital (APLD.US) ranks third, holding about 7.72 million shares with a market value of approximately $7.77 million, accounting for 3.78% of the portfolio. Nebius (NBIS.US) ranks fourth, holding about 1.19 million shares with a market value of approximately $65.87 million, accounting for 2.19% of the portfolio. Biotechnology company Recursion Pharmaceuticals (RXRX.US) ranks fifth, holding about 7.71 million shares with a market value of approximately $38.99 million, accounting for 3.55% of the portfolio. Chinese autonomous driving company WeRide (WRD.US) ranks sixth, holding about 1.74 million shares with a market value of approximately $13.7 million, accounting for 2.06% of the portfolio.